Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 28

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis

Monaghan, Phillip J., Keevil, Brian G., Trainer, Peter J. · 2013 · Reviews in Endocrine and Metabolic Disorders

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11154-013-9240-1

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 62

  1. Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods. 2009;347(1–2):3–11. · DOI · Paper page
  2. Sturgeon CM, Viljoen A. Analytical error and interference in immunoassay: Minimizing risk. Ann Clin Biochem. 2011;48:418–32. · DOI · Paper page
  3. Bell DA, Florkowski CM, Lewis JG, Crooke MJ. Plasma poltergeists: a negative cortisol interference leading to a false diagnosis of adrenal insufficiency. Clin Chim Acta. 2012;413(15–16):1298–300. · DOI
  4. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev. 2004;25(2):105–20.
  5. Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW. Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem. 2011;44:77–88. · DOI · Paper page
  6. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 2005;38(4):328–34. · DOI · Paper page
  7. Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem. 2010;56(8):1234–44. · DOI · Paper page
  8. Annesley TM. Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry. Clin Chem. 2007;53(10):1827–34. · doi:10.1373/clinchem.2007.090811
  9. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877:2198–207. · DOI · Paper page
  10. Annesley TM. Ion suppression in mass spectrometry. Clin Chem. 2003;49(7):1041–4. · DOI · Paper page
  11. Ionita IA, Fast DM, Akhlaghi F. Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877(8–9):765–72. · DOI
  12. Duxbury K, Owen LJ, Gillingwater S, Keevil BG. Naturally occurring isotopes of an analyte can interfere with doubly deuterated internal standard measurement. Ann Clin Biochem. 2008;45:210–2. · doi:10.1258/acb.2007.007137
  13. Honour JW. Development and validation of a quantitative assay based on tandem mass spectrometry. Ann Clin Biochem. 2011;48:97–111. · DOI
  14. Owen LJ, Keevil BG Testosterone measurement by mass spectrometry – a tale of three internal standards. Presented at Society for Endocrinology BES 2012, Harrogate, UK. Endocrine Abstracts, 2012;28:P30.
  15. Mendel CM. The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J Androl. 1992;13(2):107–16. · DOI
  16. van Seters AP, Moolenaar AJ. Mitotane increases the blood levels of hormone-binding proteins. Acta Endocrinol. 1991;124(5):526–33. · DOI
  17. Alexandraki KI, Kaltsas GA, le Roux CW, Fassnacht M, Ajodha S, Christ-Crain M, et al. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. Clin Endocrinol. 2010;72:305–11. · DOI
  18. Veytsman I, Nieman L, Fojo T. Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma. J Clin Oncol. 2009;27(27):4619–29. · DOI
  19. Cameron A, Henley D, Carrell R, Zhou A, Clarke A, Lightman S. Temperature-responsive release of cortisol from its binding globulin: a protein thermocouple. J Clin Endocrinol Metab. 2010;95(10):4689–95. · DOI
  20. Vogeser M, Briegel J, Zachoval R. Dialyzable free cortisol after stimulation with synacthen. Clin Biochem. 2002;35(7):539–43. · DOI
  21. Perogamvros I, Kayahara M, Trainer PJ, Ray DW. Serum regulates cortisol bioactivity by corticosteroid-binding globulin dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches. Clin Endocrinol. 2011;75(1):31–8. · DOI
  22. Kirchhoff F, Briegel J, Vogeser M. Quantification of free serum cortisol based on equilibrium dialysis and isotope dilution-liquid chromatography-tandem mass spectrometry. Clin Biochem. 2011;44(10–11):894–9. · DOI
  23. Lee S, Kwon S, Shin HJ, Lim HS, Singh RJ, Lee K-R, et al. Simultaneous quantitative analysis of salivary cortisol and cortisone in Korean adults using LC-MS/MS. BMB Reps. 2010;43(7):506–11. · DOI
  24. Raff H, Findling JW. Biomarkers: salivary cortisol or cortisone? Nat Rev Endocrinol. 2010;6(12):658–60. · DOI
  25. Jones RL, Owen LJ, Adaway JE, Keevil BG. Simultaneous analysis of cortisol and cortisone in saliva using XLC-MS/MS for fully automated online solid phase extraction. J Chromatogr B Anal Technol Biomed Life Sci. 2012;881–882, 42–48. · DOI · Paper page
  26. Restituto P, Galofré JC, Gil MJ, Mugueta C, Santos S, Monreal JI, et al. Advantage of salivary cortisol measurement ion the diagnosis of glucocorticoid related disorders. Clin Biochem. 2008;41:688–92. · DOI
  27. Deutschbein T, Unger N, Mann K, Petersenn S. Diagnosis of secondary adrenal insufficiency: unstimulated early morning cortisol saliva and serum in comparison with the insulin tolerance test. Horm Metab Res. 2009;41:834–9. · DOI
  28. Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, et al. Salivary cortisol as a diagnostic tool for Cushing’s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur J Endocrinol. 2012;166:613–8. · DOI · Paper page
  29. Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1994;40(5):603–9. · DOI · Paper page
  30. Gibney J, Healy M-L, Smith TP, McKenna TJ. A simple and cost-effective approach to assessment of pituitary adrenocorticotropin and growth hormone reserve: combined use of the overnight metyrapone test and insulin-like growth factor-I standard deviation scores. J Clin Endocrinol Metab. 2008;93(10):3763–8. · DOI
  31. Koal T, Schmiederer D, Pham-Tuan H, Röhring C, Rauh M. Standardized LC-MS/MS based steroid hormone profile-analysis. J Steroid Biochem Mol Biol. 2012;129:129–38. · DOI · Paper page
  32. Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol. 2001;87(5):379–85. · DOI
  33. Taylor RL, Grebe SK, Singh RJ. Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem. 2004;50(12):2345–52. · DOI
  34. Taylor NF, Chan AOK. New strategies for detecting steroid metabolic disorders-panelling vs. profiling. Clin Chem. 2012;58(8):1262–3. · DOI
  35. Dhillon K, Ho T, Rich P, Xu D, Lorey F, She J, et al. An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns. Clin Chim Acta. 2011;412:2076–84. · DOI
  36. Campbell DJ, Nussberger J, Stowasser M, Jan Danser AH, Morganti A, Frandsen E, et al. Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem. 2009;55(5):867–77. · DOI · Paper page
  37. Pizzolo F, Raffaelli R, Memmo A, Chiecchi L, Pavan C, Guarini P, et al. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. J Hypertens. 2010;28(1):135–42. · DOI
  38. Bystrom CE, Salameh W, Reitz R, Clarke NJ. Plasma renin activity by LC-MS/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity. Clin Chem. 2010;56(10):1561–9. · DOI
  39. Sealey JE, Laragh JH. Plasma renin activity enzyme-kinetic assay: protection of angiotensin I from bacterial degradation. Clin Chem. 2011;57(3):529–30. · DOI
  40. Carter S, Owen LJ, Kerstens MN, Dullaart RPF, Keevil BG. A liquid chromatography tandem mass spectrometry assay for plasma renin activity using online solid-phase extraction. Ann Clin Biochem. 2012;49:570–9. · DOI
  41. Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem. 2006;52(9):1749–55. · DOI
  42. Turpeinen U, Hamalainen E, Stenman UH. Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2008;862(1–2):113–8. · DOI
  43. Taylor PJ, Cooper DP, Gordon RD, Stowasser M. Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem. 2009;55(6):1155–62. · DOI
  44. Van Der Gugten JC, Dubland J, Liu HF, Wang A, Joseph C, Holmes DT. Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system. J Clin Pathol. 2012;65(5):457–62. · DOI
  45. Guo T, Taylor RL, Singh RJ, Soldin SJ. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta. 2006;372(1–2):76–82. · DOI · Paper page
  46. Djedovic NK, Rainbow SJ. Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing’s syndrome. Ann Clin Biochem. 2011;48:542–9. · DOI
  47. Remer T, Maser-Gluth C. Simultaneous measurement of urinary free cortisol and cortisone for the assessment of functional glucocorticoid activity. Clin Chem. 2007;53(10):1870–1. · DOI
  48. Hempen C, Elfering S, Mulder AHL, van den Bergh FAJTM, Maatman RGHJ. Dexamethasone suppression test: development of a method for simultaneous determination of cortisol and dexamethasone in human plasma by liquid chromatography/tandem mass spectrometry. Ann Clin Biochem. 2012;49:170–6. · DOI
  49. Peng C-C, Templeton I, Thummel KE, Davis C, Kunze KL, Isoherranen N. Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo. Clin Pharmacol Ther. 2011;89(6):888–95. · DOI
  50. Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, et al. Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2010;95(10):4555–9. · DOI
  51. Erickson D, Singh RJ, Sathananthan A, Vella A, Bryant SC. Late-night salivary cortisol for diagnosis of Cushing’s syndrome by liquid chromatography/tandem mass spectrometry. Clin Endocrinol. 2012;76:467–72. · DOI
  52. Gröschl M. Current status of salivary hormone analysis. Clin Chem. 2008;54(11):1759–69. · DOI · Paper page
  53. Raff H. Salivary cortisol and the diagnosis of Cushing’s syndrome: a coming of age. Endocrine. 2012;41(3):353–4. · DOI
  54. Ceglarek U, Werner M, Kortz L, Körner A, Kiess W, Thiery J, et al. Preclinical challenges in steroid analysis of human samples. J Steroid Biochem Mol Biol. 2010;121:505–12. · DOI
  55. Tritos NA, Biller BMK. Advances in medical therapies for Cushing’s syndrome. Discov Med. 2012;13(69):171–9.
  56. Turner HE, Wass JAH. Oxford handbook of endocrinology and diabetes; a comprehensive guide to clinical management. 2nd ed. Oxford: Oxford University Press; 2009. p. 148. · DOI
  57. Trainer PJ, Eastment C, Grossman AB, Wheeler MJ, Perry L, Besser GM. The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing’s syndrome. Clin Endocrinol. 1993;39:441–3. · DOI
  58. McWhinney BC, Ward G, Pickman PE. Improved HPLC method for simultaneous analysis of cortisol, 11-deoxycortisol, prednisolone, methylprednisolone, and dexamethasone in serum and urine. Clin Chem. 1996;42:979–81. · DOI
  59. Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG, Darby D. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone. Ann Clin Biochem. 2011;48:441–6. · DOI · Paper page
  60. Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG, Darby D. Response to ‘Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone’ by Halsall, et al. Ann Clin Biochem. 2012;49(2):204–5. · DOI
  61. Schmidt-Reinwald A, Pruessner JC, Hellhammer DH, Federenko I, Rohleder N, Schürmeyer TH, et al. The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci. 1999;64(18):1653–60. · DOI · Paper page
  62. van den Ouweland JMW, Kema IP. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory. J Chromatogr B Anal Technol Biomed Life Sci. 2012;883–884:18–32. · DOI · Paper page

Cited by

See all 28

Metadata

Authors
Monaghan, P. J., Keevil, B. G., & Trainer, P. J.
Venue
Reviews in Endocrine and Metabolic Disorders
Published
2013-03-15
Volume
14
Issue
2
Pages
143-157
ISSN
  • 1389-9155
  • 1573-2606
Cited by
28
References
23
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The use of mass spectrometry to improve the diagnosis and the management of the HPA axis. https://app.cochat.ai/papers/10.1007/s11154-013-9240-1
The paper
Monaghan, P. J., Keevil, B. G., & Trainer, P. J. (2013). The use of mass spectrometry to improve the diagnosis and the management of the HPA axis. Reviews in Endocrine and Metabolic Disorders. https://doi.org/10.1007/s11154-013-9240-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.